APO Research

APO RESEARCH · REPORT

Demineralized Bone Matrix (DBM)

Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.

Product & engineering

Understand the product.

Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.

Selected research

Market Outlook & Growth Opportunities

Global Demineralized Bone Matrix (DBM) Market Outlook and Growth Opportunities 2026

Market perspective

Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.

Global Demineralized Bone Matrix (DBM) key players include Medtronic, J &J (DePuy Synthes), SeaSpine, Xtant Medical, etc. Global top four manufacturers hold a share over 70%.

North America is the largest market, with a share about 55%, followed by Asia-Pacific, and Europe, both have a share about 40 percent.

Read the full market overview

In terms of product, Gel is the largest segment, with a share over 40%. And in terms of application, the largest application is Spine Surgery, followed by Trauma Surgery, Dental Surgery.

This report provides an overview of the global Demineralized Bone Matrix (DBM) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Demineralized Bone Matrix (DBM) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Demineralized Bone Matrix (DBM) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Demineralized Bone Matrix (DBM) market size, projected growth trends, production technologies, key applications, and end-use industries.

Demineralized Bone Matrix (DBM) Segment by Company

Medtronic

J &J (DePuy Synthes)

Zimmer Biomet

Stryker

SeaSpine

Straumann

Xtant Medical

Wright Medical Group

Hans Biomed

Arthrex

Demineralized Bone Matrix (DBM) Segment by Type

Gel

Putty

Putty with Chips

Others

Demineralized Bone Matrix (DBM) Segment by Application

Dental Surgery

Spine Surgery

Trauma Surgery

Demineralized Bone Matrix (DBM) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Demineralized Bone Matrix (DBM) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Demineralized Bone Matrix (DBM) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Demineralized Bone Matrix (DBM) significant trends, drivers, influence factors in global and regions.

6. To analyze Demineralized Bone Matrix (DBM) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Demineralized Bone Matrix (DBM) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Demineralized Bone Matrix (DBM) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Demineralized Bone Matrix (DBM).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Demineralized Bone Matrix (DBM) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Demineralized Bone Matrix (DBM) industry.

Chapter 3: Detailed analysis of Demineralized Bone Matrix (DBM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Demineralized Bone Matrix (DBM) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Demineralized Bone Matrix (DBM) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Demineralized Bone Matrix (DBM) Industry Trends Table 2. Demineralized Bone Matrix (DBM) Industry Drivers Table 3. Demineralized Bone Matrix (DBM) Industry Opportunities and Challenges Table 4. Demineralized Bone Matrix (DBM) Industry Restraints Table 5. Global Demineralized Bone Matrix (DBM) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Demineralized Bone Matrix (DBM) Revenue Share by Company (2021-2026) Table 7. Global Demineralized Bone Matrix (DBM) Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Demineralized Bone Matrix (DBM) Sales Volume Share by Company (2021-2026) Table 9. Global Demineralized Bone Matrix (DBM) Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Demineralized Bone Matrix (DBM) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Demineralized Bone Matrix (DBM) Key Company Manufacturing Base & Headquarters Table 12. Global Demineralized Bone Matrix (DBM) Company, Product Type & Application Table 13. Global Demineralized Bone Matrix (DBM) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Demineralized Bone Matrix (DBM) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Gel Table 18. Significant Companies of Putty Table 19. Significant Companies of Putty with Chips Table 20. Significant Companies of Others Table 21. Global Demineralized Bone Matrix (DBM) Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Demineralized Bone Matrix (DBM) Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Demineralized Bone Matrix (DBM) Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Demineralized Bone Matrix (DBM) Sales Volume Share by Type (2021-2026) Table 25. Global Demineralized Bone Matrix (DBM) Sales Volume Share by Type (2027-2032) Table 26. Global Demineralized Bone Matrix (DBM) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Demineralized Bone Matrix (DBM) Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Demineralized Bone Matrix (DBM) Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Demineralized Bone Matrix (DBM) Sales Value Share by Type (2021-2026) Table 30. Global Demineralized Bone Matrix (DBM) Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Dental Surgery Table 32. Significant Companies of Spine Surgery Table 33. Significant Companies of Trauma Surgery Table 34. Global Demineralized Bone Matrix (DBM) Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Demineralized Bone Matrix (DBM) Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Demineralized Bone Matrix (DBM) Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Demineralized Bone Matrix (DBM) Sales Volume Share by Application (2021-2026) Table 38. Global Demineralized Bone Matrix (DBM) Sales Volume Share by Application (2027-2032) Table 39. Global Demineralized Bone Matrix (DBM) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Demineralized Bone Matrix (DBM) Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Demineralized Bone Matrix (DBM) Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Demineralized Bone Matrix (DBM) Sales Value Share by Application (2021-2026) Table 43. Global Demineralized Bone Matrix (DBM) Sales Value Share by Application (2027-2032) Table 44. Global Demineralized Bone Matrix (DBM) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Demineralized Bone Matrix (DBM) Sales by Region (2021-2026) & (K Units) Table 46. Global Demineralized Bone Matrix (DBM) Sales Market Share by Region (2021-2026) Table 47. Global Demineralized Bone Matrix (DBM) Sales by Region (2027-2032) & (K Units) Table 48. Global Demineralized Bone Matrix (DBM) Sales Market Share by Region (2027-2032) Table 49. Global Demineralized Bone Matrix (DBM) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Demineralized Bone Matrix (DBM) Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Demineralized Bone Matrix (DBM) Sales Value Share by Region (2021-2026) Table 52. Global Demineralized Bone Matrix (DBM) Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Demineralized Bone Matrix (DBM) Sales Value Share by Region (2027-2032) Table 54. Global Demineralized Bone Matrix (DBM) Market Average Price (USD/Unit) by Region (2021-2026) Table 55. Global Demineralized Bone Matrix (DBM) Market Average Price (USD/Unit) by Region (2027-2032) Table 56. Global Demineralized Bone Matrix (DBM) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Demineralized Bone Matrix (DBM) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Demineralized Bone Matrix (DBM) Sales by Country (2021-2026) & (K Units) Table 59. Global Demineralized Bone Matrix (DBM) Sales Market Share by Country (2021-2026) Table 60. Global Demineralized Bone Matrix (DBM) Sales by Country (2027-2032) & (K Units) Table 61. Global Demineralized Bone Matrix (DBM) Sales Market Share by Country (2027-2032) Table 62. Global Demineralized Bone Matrix (DBM) Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Demineralized Bone Matrix (DBM) Sales Value Market Share by Country (2021-2026) Table 64. Global Demineralized Bone Matrix (DBM) Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Demineralized Bone Matrix (DBM) Sales Value Market Share by Country (2027-2032) Table 66. Medtronic Company Information Table 67. Medtronic Business Overview Table 68. Medtronic Demineralized Bone Matrix (DBM) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 69. Medtronic Demineralized Bone Matrix (DBM) Product Portfolio Table 70. Medtronic Recent Development Table 71. J &J (DePuy Synthes) Company Information Table 72. J &J (DePuy Synthes) Business Overview Table 73. J &J (DePuy Synthes) Demineralized Bone Matrix (DBM) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. J &J (DePuy Synthes) Demineralized Bone Matrix (DBM) Product Portfolio Table 75. J &J (DePuy Synthes) Recent Development Table 76. Zimmer Biomet Company Information Table 77. Zimmer Biomet Business Overview Table 78. Zimmer Biomet Demineralized Bone Matrix (DBM) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Zimmer Biomet Demineralized Bone Matrix (DBM) Product Portfolio Table 80. Zimmer Biomet Recent Development Table 81. Stryker Company Information Table 82. Stryker Business Overview Table 83. Stryker Demineralized Bone Matrix (DBM) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Stryker Demineralized Bone Matrix (DBM) Product Portfolio Table 85. Stryker Recent Development Table 86. SeaSpine Company Information Table 87. SeaSpine Business Overview Table 88. SeaSpine Demineralized Bone Matrix (DBM) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. SeaSpine Demineralized Bone Matrix (DBM) Product Portfolio Table 90. SeaSpine Recent Development Table 91. Straumann Company Information Table 92. Straumann Business Overview Table 93. Straumann Demineralized Bone Matrix (DBM) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Straumann Demineralized Bone Matrix (DBM) Product Portfolio Table 95. Straumann Recent Development Table 96. Xtant Medical Company Information Table 97. Xtant Medical Business Overview Table 98. Xtant Medical Demineralized Bone Matrix (DBM) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Xtant Medical Demineralized Bone Matrix (DBM) Product Portfolio Table 100. Xtant Medical Recent Development Table 101. Wright Medical Group Company Information Table 102. Wright Medical Group Business Overview Table 103. Wright Medical Group Demineralized Bone Matrix (DBM) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Wright Medical Group Demineralized Bone Matrix (DBM) Product Portfolio Table 105. Wright Medical Group Recent Development Table 106. Hans Biomed Company Information Table 107. Hans Biomed Business Overview Table 108. Hans Biomed Demineralized Bone Matrix (DBM) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Hans Biomed Demineralized Bone Matrix (DBM) Product Portfolio Table 110. Hans Biomed Recent Development Table 111. Arthrex Company Information Table 112. Arthrex Business Overview Table 113. Arthrex Demineralized Bone Matrix (DBM) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Arthrex Demineralized Bone Matrix (DBM) Product Portfolio Table 115. Arthrex Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Demineralized Bone Matrix (DBM) Distributors List Table 119. Demineralized Bone Matrix (DBM) Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Demineralized Bone Matrix (DBM) Product Image Figure 2. Global Demineralized Bone Matrix (DBM) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Demineralized Bone Matrix (DBM) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Demineralized Bone Matrix (DBM) Sales (2021-2032) & (K Units) Figure 5. Global Demineralized Bone Matrix (DBM) Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Demineralized Bone Matrix (DBM) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Gel Image Figure 10. Putty Image Figure 11. Putty with Chips Image Figure 12. Others Image Figure 13. Global Demineralized Bone Matrix (DBM) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Demineralized Bone Matrix (DBM) Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Demineralized Bone Matrix (DBM) Sales Volume Share by Type (2021-2032) Figure 16. Global Demineralized Bone Matrix (DBM) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Demineralized Bone Matrix (DBM) Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Demineralized Bone Matrix (DBM) Sales Value Share by Type (2021-2032) Figure 19. Dental Surgery Image Figure 20. Spine Surgery Image Figure 21. Trauma Surgery Image Figure 22. Global Demineralized Bone Matrix (DBM) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Demineralized Bone Matrix (DBM) Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Demineralized Bone Matrix (DBM) Sales Volume Share by Application (2021-2032) Figure 25. Global Demineralized Bone Matrix (DBM) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Demineralized Bone Matrix (DBM) Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Demineralized Bone Matrix (DBM) Sales Value Share by Application (2021-2032) Figure 28. Global Demineralized Bone Matrix (DBM) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Demineralized Bone Matrix (DBM) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Demineralized Bone Matrix (DBM) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Demineralized Bone Matrix (DBM) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Demineralized Bone Matrix (DBM) Sales Value (2021-2032) & (US$ Million) Figure 33. North America Demineralized Bone Matrix (DBM) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Demineralized Bone Matrix (DBM) Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Demineralized Bone Matrix (DBM) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Demineralized Bone Matrix (DBM) Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Demineralized Bone Matrix (DBM) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Demineralized Bone Matrix (DBM) Sales Value (2021-2032) & (US$ Million) Figure 39. South America Demineralized Bone Matrix (DBM) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Demineralized Bone Matrix (DBM) Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Demineralized Bone Matrix (DBM) Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Demineralized Bone Matrix (DBM) Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Demineralized Bone Matrix (DBM) Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Gel
  • Putty
  • Putty with Chips
  • Others
Applications
  • Dental Surgery
  • Spine Surgery
  • Trauma Surgery
Companies covered
  • Medtronic
  • J &J (DePuy Synthes)
  • Zimmer Biomet
  • Stryker
  • SeaSpine
  • Straumann
  • Xtant Medical
  • Wright Medical Group
  • Hans Biomed
  • Arthrex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Demineralized Bone Matrix (DBM) Sales Value (2021-2032)
  4. 1.2.2 Global Demineralized Bone Matrix (DBM) Sales Volume (2021-2032)
  5. 1.2.3 Global Demineralized Bone Matrix (DBM) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Demineralized Bone Matrix (DBM) Market Dynamics
  1. 2.1 Demineralized Bone Matrix (DBM) Industry Trends
  2. 2.2 Demineralized Bone Matrix (DBM) Industry Drivers
  3. 2.3 Demineralized Bone Matrix (DBM) Industry Opportunities and Challenges
  4. 2.4 Demineralized Bone Matrix (DBM) Industry Restraints
3 Demineralized Bone Matrix (DBM) Market by Company
  1. 3.1 Global Demineralized Bone Matrix (DBM) Company Revenue Ranking in 2025
  2. 3.2 Global Demineralized Bone Matrix (DBM) Revenue by Company (2021-2026)
  3. 3.3 Global Demineralized Bone Matrix (DBM) Sales Volume by Company (2021-2026)
  4. 3.4 Global Demineralized Bone Matrix (DBM) Average Price by Company (2021-2026)
  5. 3.5 Global Demineralized Bone Matrix (DBM) Company Ranking (2024-2026)
  6. 3.6 Global Demineralized Bone Matrix (DBM) Company Manufacturing Base and Headquarters
  7. 3.7 Global Demineralized Bone Matrix (DBM) Company Product Type and Application
  8. 3.8 Global Demineralized Bone Matrix (DBM) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Demineralized Bone Matrix (DBM) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Demineralized Bone Matrix (DBM) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Demineralized Bone Matrix (DBM) Market by Type
  1. 4.1 Demineralized Bone Matrix (DBM) Type Introduction
  2. 4.1.1 Gel
  3. 4.1.2 Putty
  4. 4.1.3 Putty with Chips
  5. 4.1.4 Others
  6. 4.2 Global Demineralized Bone Matrix (DBM) Sales Volume by Type
  7. 4.2.1 Global Demineralized Bone Matrix (DBM) Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Demineralized Bone Matrix (DBM) Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Demineralized Bone Matrix (DBM) Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Demineralized Bone Matrix (DBM) Sales Value by Type
  11. 4.3.1 Global Demineralized Bone Matrix (DBM) Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Demineralized Bone Matrix (DBM) Sales Value by Type (2021-2032)
  13. 4.3.3 Global Demineralized Bone Matrix (DBM) Sales Value Share by Type (2021-2032)
5 Demineralized Bone Matrix (DBM) Market by Application
  1. 5.1 Demineralized Bone Matrix (DBM) Application Introduction
  2. 5.1.1 Dental Surgery
  3. 5.1.2 Spine Surgery
  4. 5.1.3 Trauma Surgery
  5. 5.2 Global Demineralized Bone Matrix (DBM) Sales Volume by Application
  6. 5.2.1 Global Demineralized Bone Matrix (DBM) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Demineralized Bone Matrix (DBM) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Demineralized Bone Matrix (DBM) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Demineralized Bone Matrix (DBM) Sales Value by Application
  10. 5.3.1 Global Demineralized Bone Matrix (DBM) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Demineralized Bone Matrix (DBM) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Demineralized Bone Matrix (DBM) Sales Value Share by Application (2021-2032)
6 Demineralized Bone Matrix (DBM) Regional Sales and Value Analysis
  1. 6.1 Global Demineralized Bone Matrix (DBM) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Demineralized Bone Matrix (DBM) Sales by Region (2021-2032)
  3. 6.2.1 Global Demineralized Bone Matrix (DBM) Sales by Region: 2021-2026
  4. 6.2.2 Global Demineralized Bone Matrix (DBM) Sales by Region (2027-2032)
  5. 6.3 Global Demineralized Bone Matrix (DBM) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Demineralized Bone Matrix (DBM) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Demineralized Bone Matrix (DBM) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Demineralized Bone Matrix (DBM) Sales Value by Region (2027-2032)
  9. 6.5 Global Demineralized Bone Matrix (DBM) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Demineralized Bone Matrix (DBM) Sales Value (2021-2032)
  12. 6.6.2 North America Demineralized Bone Matrix (DBM) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Demineralized Bone Matrix (DBM) Sales Value (2021-2032)
  15. 6.7.2 Europe Demineralized Bone Matrix (DBM) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Demineralized Bone Matrix (DBM) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Demineralized Bone Matrix (DBM) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Demineralized Bone Matrix (DBM) Sales Value (2021-2032)
  21. 6.9.2 South America Demineralized Bone Matrix (DBM) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Demineralized Bone Matrix (DBM) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Demineralized Bone Matrix (DBM) Sales Value Share by Country, 2025 VS 2032
7 Demineralized Bone Matrix (DBM) Country-level Sales and Value Analysis
  1. 7.1 Global Demineralized Bone Matrix (DBM) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Demineralized Bone Matrix (DBM) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Demineralized Bone Matrix (DBM) Sales by Country (2021-2032)
  4. 7.3.1 Global Demineralized Bone Matrix (DBM) Sales by Country (2021-2026)
  5. 7.3.2 Global Demineralized Bone Matrix (DBM) Sales by Country (2027-2032)
  6. 7.4 Global Demineralized Bone Matrix (DBM) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Demineralized Bone Matrix (DBM) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Demineralized Bone Matrix (DBM) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Demineralized Bone Matrix (DBM) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Demineralized Bone Matrix (DBM) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Demineralized Bone Matrix (DBM) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Demineralized Bone Matrix (DBM) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Demineralized Bone Matrix (DBM) Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 J &J (DePuy Synthes)
  8. 8.2.1 J &J (DePuy Synthes) Company Information
  9. 8.2.2 J &J (DePuy Synthes) Business Overview
  10. 8.2.3 J &J (DePuy Synthes) Demineralized Bone Matrix (DBM) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 J &J (DePuy Synthes) Demineralized Bone Matrix (DBM) Product Portfolio
  12. 8.2.5 J &J (DePuy Synthes) Recent Developments
  13. 8.3 Zimmer Biomet
  14. 8.3.1 Zimmer Biomet Company Information
  15. 8.3.2 Zimmer Biomet Business Overview
  16. 8.3.3 Zimmer Biomet Demineralized Bone Matrix (DBM) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Zimmer Biomet Demineralized Bone Matrix (DBM) Product Portfolio
  18. 8.3.5 Zimmer Biomet Recent Developments
  19. 8.4 Stryker
  20. 8.4.1 Stryker Company Information
  21. 8.4.2 Stryker Business Overview
  22. 8.4.3 Stryker Demineralized Bone Matrix (DBM) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Stryker Demineralized Bone Matrix (DBM) Product Portfolio
  24. 8.4.5 Stryker Recent Developments
  25. 8.5 SeaSpine
  26. 8.5.1 SeaSpine Company Information
  27. 8.5.2 SeaSpine Business Overview
  28. 8.5.3 SeaSpine Demineralized Bone Matrix (DBM) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 SeaSpine Demineralized Bone Matrix (DBM) Product Portfolio
  30. 8.5.5 SeaSpine Recent Developments
  31. 8.6 Straumann
  32. 8.6.1 Straumann Company Information
  33. 8.6.2 Straumann Business Overview
  34. 8.6.3 Straumann Demineralized Bone Matrix (DBM) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Straumann Demineralized Bone Matrix (DBM) Product Portfolio
  36. 8.6.5 Straumann Recent Developments
  37. 8.7 Xtant Medical
  38. 8.7.1 Xtant Medical Company Information
  39. 8.7.2 Xtant Medical Business Overview
  40. 8.7.3 Xtant Medical Demineralized Bone Matrix (DBM) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Xtant Medical Demineralized Bone Matrix (DBM) Product Portfolio
  42. 8.7.5 Xtant Medical Recent Developments
  43. 8.8 Wright Medical Group
  44. 8.8.1 Wright Medical Group Company Information
  45. 8.8.2 Wright Medical Group Business Overview
  46. 8.8.3 Wright Medical Group Demineralized Bone Matrix (DBM) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Wright Medical Group Demineralized Bone Matrix (DBM) Product Portfolio
  48. 8.8.5 Wright Medical Group Recent Developments
  49. 8.9 Hans Biomed
  50. 8.9.1 Hans Biomed Company Information
  51. 8.9.2 Hans Biomed Business Overview
  52. 8.9.3 Hans Biomed Demineralized Bone Matrix (DBM) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hans Biomed Demineralized Bone Matrix (DBM) Product Portfolio
  54. 8.9.5 Hans Biomed Recent Developments
  55. 8.10 Arthrex
  56. 8.10.1 Arthrex Company Information
  57. 8.10.2 Arthrex Business Overview
  58. 8.10.3 Arthrex Demineralized Bone Matrix (DBM) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Arthrex Demineralized Bone Matrix (DBM) Product Portfolio
  60. 8.10.5 Arthrex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Demineralized Bone Matrix (DBM) Value Chain Analysis
  2. 9.1.1 Demineralized Bone Matrix (DBM) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Demineralized Bone Matrix (DBM) Sales Mode & Process
  6. 9.2 Demineralized Bone Matrix (DBM) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Demineralized Bone Matrix (DBM) Distributors
  9. 9.2.3 Demineralized Bone Matrix (DBM) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research